TMEM184A promotes progression and drug resistance in colorectal cancer: a bioinformatics and clinical study.

In TCGA, higher TMEM184A expression associated with larger primary tumours (T), distant metastasis (M) and more advanced clinical stage, with an increasing trend across N stage despite non-significance (Fig. 4 E).

also in 63,971 other papers